Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.


Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 08 01 2021
accepted: 13 02 2021
pubmed: 12 3 2021
medline: 22 4 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all COVID-19 cases confirmed in Sweden by mid-September 2020 (68,575 non-hospitalized, 2494 ICU hospitalized, and 13,589 non-ICU hospitalized) and 434,081 randomly sampled general-population controls. Older age was the strongest risk factor for hospitalization, although the odds of ICU hospitalization decreased after 60-69 years and, after controlling for other risk factors, the odds of non-ICU hospitalization showed no trend after 40-49 years. Residence in a long-term care facility was associated with non-ICU hospitalization. Male sex and the presence of at least one investigated comorbidity or prescription medication were associated with both ICU and non-ICU hospitalization. Three comorbidities associated with both ICU and non-ICU hospitalization were asthma, hypertension, and Down syndrome. History of cancer was not associated with COVID-19 hospitalization, but cancer in the past year was associated with non-ICU hospitalization, after controlling for other risk factors. Cardiovascular disease was weakly associated with non-ICU hospitalization for COVID-19, but not with ICU hospitalization, after adjustment for other risk factors. Excess mortality was observed in both hospitalized and non-hospitalized COVID-19 cases. These results confirm that severe COVID-19 is related to age, sex, and comorbidity in general. The study provides new evidence that hypertension, asthma, Down syndrome, and residence in a long-term care facility are associated with severe COVID-19.

Identifiants

pubmed: 33704634
doi: 10.1007/s10654-021-00732-w
pii: 10.1007/s10654-021-00732-w
pmc: PMC7946619
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

287-298

Références

Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020;323:709–10.
doi: 10.1001/jama.2020.1097
World Health Organization. Listings of WHO’s response to COVID-19. https://www.who.int/news/item/29-06-2020-covidtimeline . Accessed 21 Dec 2020.
Tian H, Liu Y, Li Y, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020;368:638–42.
doi: 10.1126/science.abb6105
Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.
doi: 10.1136/bmj.m1985
Kim L, Garg S, O’Halloran A, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Clin Infect Dis. 2020;2:16.
Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966.
doi: 10.1136/bmj.m1966
Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.
doi: 10.1038/s41586-020-2521-4
Reilev M, Kristensen KB, Pottegård A, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49:1468–81.
doi: 10.1093/ije/dyaa140
Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–70.
doi: 10.1016/S0140-6736(20)31189-2
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.
doi: 10.1056/NEJMoa2002032
Fosbøl EL, Butt JH, Østergaard L, et al. Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. JAMA. 2020;324:168–77.
doi: 10.1001/jama.2020.11301
Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8:813–22.
doi: 10.1016/S2213-8587(20)30272-2
Brooke HL, Talbäck M, Hörnblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32:765–73.
doi: 10.1007/s10654-017-0316-1
Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
doi: 10.1186/1471-2458-11-450
Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register-a sample survey for year 1998. Acta Oncol (Madr). 2009;48:27–33.
doi: 10.1080/02841860802247664
Wettermark B, Hammar N, MichaelFored C, et al. The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16:726–35.
doi: 10.1002/pds.1294
Kroksgård A. Kvalitetsdeklaration-statistik om socialtjänstinsatser till äldre 2019. Stockholm [SE]: Socialstyrelsen; 2020. https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/statistik/2020-4-6745-kvalitetsdeklaration.pdf
Svenska Intesivvårdsregistret. Svenska Intesivvårdsregistret Årsrapport 2019. 2020. https://www.icuregswe.org/globalassets/arsrapporter/arsrapport_2019_final.pdf
Statistiska centralbyrån. Befolkning efter ålder och kön. År 1860–2019. https://www.statistikdatabasen.scb.se/pxweb/sv/ssd/START__BE__BE0101__BE0101A/BefolkningR1860/ #. Accessed 27 Nov 2020.
Clift A, Coupland C, Keogh R, et al. COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults. Ann Intern Med. 2020;21:20–4986.
Mancia G, Rea F, Ludergnani M, et al. Renin–angiotensin–aldosterone system blockers and the risk of COVID-19. N Engl J Med. 2020;382:2431–40.
doi: 10.1056/NEJMoa2006923
Mehta N, Kalra A, Nowacki AS, et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1020–6.
doi: 10.1001/jamacardio.2020.1855
Cohen JB, Hanff TC, William P, et al. Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. Lancet Respir Med. 2021;S2213–2600(20):30558.
Lopes RD, Macedo AVS, de Barros E, Silva PGM, et al. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA. 2021;325:254–64.
doi: 10.1001/jama.2020.25864
Wang Z, Deng H, Ou C, et al. Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: a systematic review and meta-analysis without cases duplication. Medicine (Baltimore). 2020;99:e23327.
doi: 10.1097/MD.0000000000023327
Bae S, Kim SR, Kim M-N, et al. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2020;5:1–8.
Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81:e16-25.
doi: 10.1016/j.jinf.2020.04.021
Burki T. England and Wales see 20 000 excess deaths in care homes. Lancet. 2020;395:1602.
doi: 10.1016/S0140-6736(20)31199-5 pubmed: 32446403 pmcid: 7241982
Folkhälsomyndigheten. Uppdrag för utökad diagnostik av covid-19. https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/mars/uppdrag-for-utokad-diagnostik-av-covid-19/ . Accessed 21 Dec 2020.
Folkhälsomyndigheten. Nationell strategi för att utöka provtagningen för covid-19. https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/april/nationell-strategi-for-att-utoka-provtagningen-for-covid-19/ . Accessed 21 Dec 2020.
Regeringen. Regeringen satsar 5,9 miljarder på utökad testning och smittspårning. https://www.regeringen.se/pressmeddelanden/2020/06/regeringen-satsar-59-miljarder-pa-utokad-testning-och-smittsparning/ . Accessed 21 Dec 2020.

Auteurs

Jonathan Bergman (J)

Unit of Geriatric Medicine, Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden.

Marcel Ballin (M)

Unit of Geriatric Medicine, Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden.
Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden.

Anna Nordström (A)

Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden.
School of Sport Sciences, UiT the Arctic University of Norway, Tromsø, Norway.

Peter Nordström (P)

Unit of Geriatric Medicine, Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden. peter.nordstrom@umu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH